𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Final results of a phase II single-institutional trial with hyperfractionated radiation therapy (HFX) and four-weekly continuous cisplatin in locally advanced head and neck carcinoma

✍ Scribed by Arias, F.; Asín, G.; Uzcanga, M. I.; Maraví, E.; Quílez, I.; Chicata, V.; Eito, C.; Viudez, A.; Hernández, I.; Mañeru, F.; Domínguez, M. A.


Book ID
121606451
Publisher
Springer Milan
Year
2013
Tongue
Spanish
Weight
237 KB
Volume
16
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Neurotoxicity in a phase I trial of cont
✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which